SOFIA (Bulgaria), November 19 (SeeNews) – Bulgarian drug producer Sopharma [BUL:3JR] said it will seek its shareholders' approval to increase its capital to 134.8 million levs ($86.4 million/68.9 million euro) from 132 million levs.